Global Buerger’s Disease Market Insights Forecasts to 2033

• The Global Buerger’s disease Market Size was Valued at USD 0.41 Billion in 2023
• The Market Size is Growing at a CAGR of 4.72% from 2023 to 2033
• The Worldwide Buerger’s disease Market Size is Expected to Reach USD 0.65 Billion by 2033
• Asia Pacific is Expected to Grow the fastest during the forecast period.

The Global Buerger’s Disease Market Size is Anticipated to Exceed USD 0.65 Billion by 2033, Growing at a CAGR of 4.72% from 2023 to 2033.

Market Overview

Buerger’s disease, also known as thromboangiitis obliterans, is a nonatherosclerotic, segmental inflammatory disease that affects small and medium arteries in the upper and lower extremities. Patients experience pain in their arms, hands, legs, and feet, often attributed to joint or neuromuscular disorders. The disease is more prevalent in Eastern Europe, South East Asia, and South America. The prevalence varies, with the lowest in Western Europe (0.5-5.6%) and the highest in India (45-63%). Males are more affected than females, with a three-to-one ratio of disease. The contributing factors for Buerger’s disease market include the rising prevalence of tobacco consumption globally, which is the leading cause of the condition. Increased awareness about the disease and advancements in diagnostic technologies are propelling early detection and treatment. The development of novel therapies, such as vascular growth factors, immune-modulating drugs, and advanced surgical interventions, is further driving market growth. Additionally, government initiatives aimed at reducing smoking and promoting public health contribute to market expansion.

Report Coverage

This research report categorizes the market for the global Buerger’s disease market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global Buerger’s disease market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global Buerger’s disease market.

Driving Factors

The primary driving factor for Buerger’s disease is the use of tobacco, both smoking and chewing, which is closely linked to its onset and progression. The disease predominantly affects individuals, particularly men under 45, who have a history of heavy tobacco consumption. Genetic predisposition and immune system abnormalities in response to tobacco toxins are also believed to contribute to its development. Environmental factors, such as cold exposure, may exacerbate symptoms, but cessation of tobacco use is crucial to prevent progression.

Restraining Factors

Buerger’s disease is primarily linked to tobacco use, making cessation crucial for prevention and treatment. The lack of biomarkers and diagnostic tests complicates early diagnosis and treatment. The disease's rarity limits research funding and targeted medicine development. Low public awareness also contributes to delayed diagnosis and treatment in many patients. Therefore, smoking cessation is essential for prevention and treatment.

Market Segmentation

The global Buerger’s disease market share is classified into diagnosis, treatment, and end-user.

• The angiography segment is expected to hold the largest share of the global Buerger’s disease market during the forecast period.

Based on the diagnosis, the global Buerger’s disease market is divided into angiography, blood tests, tissue biopsy, and others. Among these, the angiography segment is expected to hold the largest share of the global Buerger’s disease market during the forecast period. The segment is expected to grow due to its crucial role in diagnosing Buerger’s disease by visualizing blood vessel blockages and inflammation. Advancements in imaging technologies have made angiography more precise, non-invasive, and accessible, enabling earlier detection and effective treatment planning. As awareness of Buerger’s disease increases and diagnostic tools improve, the demand for angiography is expected to rise.

• The medications segment is expected to grow at the fastest CAGR in the global Buerger’s disease market during the forecast period.   

Based on the treatment, the global Buerger’s disease market is divided into medications, surgery, and others. Among these, the medications segment is expected to grow at the fastest CAGR in the global Buerger’s disease market during the forecast period. The segment is expected to grow in the Buerger's disease treatment market due to the growing focus on non-surgical interventions and advancements in drug therapies. Medications, such as vasodilators, anticoagulants, and anti-inflammatory drugs, offer a less invasive treatment option and are essential for managing symptoms, improving blood flow, and preventing disease progression.

• The hospitals segment is expected to grow at the fastest CAGR in the global Buerger’s disease market during the forecast period.   

Based on the end-user, the global Buerger’s disease market is divided into specialty clinics, hospitals, and others. Among these, the hospitals segment is expected to grow at the fastest CAGR in the global Buerger’s disease market during the forecast period. The segment is expected to grow in the Buerger's disease treatment market due to its comprehensive care and advanced diagnostic tools. They handle complex cases requiring multidisciplinary approaches, including vascular specialists, imaging technologies, and surgical options. Hospitals provide an integrated environment for early detection, medication management, and surgical interventions, and the increasing availability of advanced technologies boosts their role in managing the condition.

Regional Segment Analysis of the Global Buerger’s disease Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the global Buerger’s disease market over the predicted timeframe.

North America is anticipated to hold the largest share of the global Buerger’s disease market over the predicted timeframe. The region is expected to dominate the global Buerger's disease market due to factors such as smoking prevalence, healthcare infrastructure, and awareness of vascular diseases. The U.S. also has advanced diagnostic facilities, access to novel therapies, and ongoing research into vascular conditions. The region's emphasis on smoking cessation programs and government initiatives further solidifies its market position.

Asia Pacific is expected to grow at the fastest pace in the global Buerger’s disease market during the forecast period. The region is expected to experience rapid growth due to high smoking prevalence in countries like China, India, and Japan. This increased incidence of the disease is a major risk factor. Rising healthcare awareness, improved diagnostic technologies, and medical infrastructure advancements are driving demand for effective treatment options. Governments in the region are also promoting smoking cessation programs, further driving demand for preventive care and treatment solutions.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global Buerger’s disease market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• T2Cure GmbH
• Koninklijke Philips N.V.
• Pluristem
• General Electric Company
• STEMPEUTICS RESEARCH PVT LTD  
• Shimadzu Corporation
• FUJIFILM Holdings Corporation
• Siemens Healthcare GmbH
• Toshiba Medical Corporation
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global Buerger’s disease market based on the below-mentioned segments: 

Global Buerger’s Disease Market, By Diagnosis

• Angiography
• Blood Tests
• Tissue Biopsy
• Others

Global Buerger’s Disease Market, By Treatment

• Medications
• Surgery
• Others

Global Buerger’s Disease Market, By End-User

• Specialty Clinics
• Hospitals
• Others

Global Buerger’s Disease Market, Regional

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa